Enlivex Therapeutics
ENLV
ENLV
9 hedge funds and large institutions have $8.92M invested in Enlivex Therapeutics in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
9
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$248K | |
| 2 | +$145K | |
| 3 | +$24K | |
| 4 |
Citigroup
New York
|
+$4K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1K |
Top Sellers
| 1 | -$104K | |
| 2 | -$4K | |
| 3 | -$3K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3K |
| 5 |
VAM
Visium Asset Management
New York
|
-$1.1K |